Roberts Glore & CO Inc Novartis Ag Transaction History
Roberts Glore & CO Inc
- $328 Million
- Q2 2024
A detailed history of Roberts Glore & CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Roberts Glore & CO Inc holds 14,691 shares of NVS stock, worth $1.71 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
14,691
Previous 14,943
1.69%
Holding current value
$1.71 Million
Previous $1.45 Million
8.24%
% of portfolio
0.48%
Previous 0.44%
Shares
26 transactions
Others Institutions Holding NVS
# of Institutions
1,425Shares Held
138MCall Options Held
1.48MPut Options Held
1.54M-
Dodge & Cox San Francisco, CA12.2MShares$1.43 Billion0.82% of portfolio
-
Primecap Management CO Pasadena, CA12.2MShares$1.42 Billion0.95% of portfolio
-
Morgan Stanley New York, NY7.42MShares$865 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX7.41MShares$864 Million0.21% of portfolio
-
Loomis Sayles & CO L P5.95MShares$694 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $251B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...